Compared to rapid-acting injectable insulin, Mannkind’s inhaled insulin, Afrezza, was significantly more effective in preventing high blood sugars after eating. the 17-week study included a 13-week extension, with 141 participants aged 18 and older. Participants were using injections, closed-loop pumps, or manual insulin pumps, then some were randomly assigned to use inhaled insulin for all mealtime insulin. Complete study results will be shared on June 22, 2024 at the American Diabetes Association’s Scientific Sessions.
Read more here: https://lnkd.in/eg7etYCE
Learn more about using inhaled insulin with type 1 diabetes:
• Using Inhaled Insulin with T1D: https://lnkd.in/eiTeX6MT
• Getting Inhaled Insulin: https://lnkd.in/ed83Avnv
Ginger Vieira has lived with type 1 diabetes since 1999 along with a few other chronic illnesses! She is the Cofounder of the Diabetes Nerd Network and the Diabetes Nerd Marketing agency. Ginger has authored hundreds of articles and several books, including Exercise with Type 1 Diabetes, Pregnancy with Type 1 Diabetes, Dealing with Diabetes Burnout, and Stop Overeating During Lows. Over her 20-year career (so far) in diabetes, she’s produced hundreds of articles and videos about life with diabetes. Her background includes a Bachelor of Science in professional writing and certifications in coaching, personal training, powerlifting, and Ashtanga yoga.